Adipocyte is a distinguished academic journal published by Taylor & Francis Inc., focusing on groundbreaking research within the realms of cell biology and histology. With an impact factor that reflects its importance, the journal has achieved a Q2 ranking in Cell Biology and a prestigious Q1 ranking in Histology for 2023, cementing its reputation as a leading resource for scientists and researchers in these fields. Since transitioning to Open Access in 2019, Adipocyte has fostered a wider dissemination of knowledge, enabling unrestricted access to a wealth of studies and reviews critical for advancing the understanding of adipose tissue biology. Located in the United Kingdom, with converged years spanning from 2013 to 2024, the journal serves as an essential platform for the exchange of innovative ideas and findings, supporting the academic community's efforts to unravel the complexities related to fat cells and their implications in health and disease.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.

Neuropeptides is a prestigious, peer-reviewed journal published by Elsevier, focusing on the critical role of neuropeptides in various biological processes and their implications in cellular and molecular neuroscience, endocrinology, and neurology. With an impact factor reflecting its influence in the field and a diverse audience ranging from researchers to healthcare professionals, the journal serves as an essential platform for the dissemination of groundbreaking research from 1980 to 2024. Adhering to high academic standards, Neuropeptides holds a Q3 ranking in Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, alongside a solid Q2 ranking in both Endocrinology and Neurology. This positions the journal at the forefront of its disciplines, contributing valuable insights into the understanding of neuropeptide functions in health and disease. By not operating as an Open Access journal, it ensures sustainability in the publishing process while upholding rigorous review standards. Researchers, professionals, and students are encouraged to engage with the findings published in this journal, which plays a vital role in advancing knowledge and fostering collaboration within the neuroscientific community.

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.